1. Home
  2. IRON vs BATRA Comparison

IRON vs BATRA Comparison

Compare IRON & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$59.06

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$46.67

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
BATRA
Founded
2017
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
BATRA
Price
$59.06
$46.67
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$103.18
$57.00
AVG Volume (30 Days)
520.9K
47.8K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.40
Revenue Next Year
$283.52
$8.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$38.67
52 Week High
$99.50
$50.45

Technical Indicators

Market Signals
Indicator
IRON
BATRA
Relative Strength Index (RSI) 39.24 45.58
Support Level $57.81 $45.81
Resistance Level $64.00 $48.05
Average True Range (ATR) 2.81 1.01
MACD 0.08 -0.36
Stochastic Oscillator 16.99 20.92

Price Performance

Historical Comparison
IRON
BATRA

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: